Sorted By:

Relevance


Statement on Biosimilar User Fee Act Reauthorization

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/statement-on-biosimilar-user-fee-act-reauthorization1

Medicare Monday: Who qualifies for Part D Extra Help?

PhRMA  |  Blog Post

(Click here for Diane’s full profile.)
http://catalyst.phrma.org/medicare-monday-who-qualifies-for-part-d-extra-help

Medicare Monday: Who qualifies for Part D Extra Help?

PhRMA  |  Blog Post

(Click here for Diane’s full profile.)
http://catalyst.phrma.org/medicare-monday-who-qualifies-for-part-d-extra-help

PhRMA Lanza Nuevos Recursos del Cuidado de la Salud en Español

Access Better Coverage  |  From Our Network

Para obtener más recursos, visite www.AccessBetterCoverage.org/espanol.
http://www.accessbettercoverage.org/social-news/phrma-lanza-nuevos-recursos-del-cuidado-de-la-salud-en-espanol

PhRMA Kicks Off National Health Care Dialogue to Examine the New Era of Medicine

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/phrma-kicks-off-national-health-care-dialogue-to-examine-the-new-era-of-medicine

Statement on Biosimilar User Fee Act Reauthorization

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/statement-on-biosimilar-user-fee-act-reauthorization

New Policy Solutions for Innovative Treatment Delivery

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $51.2 billion in 2014 alone.
http://www.phrma.org/press-release/phrma-releases-new-policy-solutions-for-delivering-innovative-treatments-to-patients

Collaboration Is Key in Researching and Developing New Medicines

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-2/collaboration-is-key-in-researching-and-developing-new-medicines

New report: Decade of breakthroughs in cancer

PhRMA  |  Blog Post

In fact, the first immunotherapies for bladder cancer and for Hodgkin lymphoma were recently approved, and a new type of cellular immunotherapy, CAR-T, looks to take individualized immune-therapy to the next level.
http://catalyst.phrma.org/new-report-decade-of-breakthroughs-in-cancer

New York's 2016 Exchange Plans

PhRMA  |  Fact Sheet

States can continue to protect patients in their state through the following actions: Enforcing non-discrimination requirements, which apply to benefit design and provider networks; Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.phrma.org/fact-sheet/new-york-s-2016-exchange-plans

PhRMA Lanza Nuevos Recursos del Cuidado de la Salud en Español

PhRMA  |  Press Release

Desde el año 2000, las compañías miembros de PhRMA han invertido más de $600 mil millones en la búsqueda de nuevos tratamientos y curas, incluyendo un estimado de sólo $51.2 mil millones en 2014.
http://www.phrma.org/press-release/phrma-lanza-nuevos-recursos-del-cuidado-de-la-salud-en-espa-ol

When coverage does not equal access to care

PhRMA  |  Blog Post

[2] N.K.
http://catalyst.phrma.org/when-coverage-does-not-equal-access-to-care

Few Approved Medicines Are Commercially Successful

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-3/few-approved-medicines-are-commercially-successful

ICER puts hard-fought progress in non-small cell lung cancer treatment at risk

PhRMA  |  Blog Post

While the rest of the health care community moves forward together, ICER has dug in its heels.
http://catalyst.phrma.org/icer-puts-hard-fought-progress-in-non-small-cell-lung-cancer-treatment-at-risk

A Day In The Life

PhRMA  |  From PhRMA

                     
http://www.phrma.org/media/a-day-in-the-life

Boston Kickoff: The New Era of Medicine

PhRMA  |  Video

The event was the first in a national dialogue series PhRMA is supporting as part of its new GOBOLDLY campaign.
http://www.phrma.org/video/boston-kickoff-the-new-era-of-medicine

New Mexico

Access Better Coverage  |  From Our Network

Enforcing non-discrimination requirements, which apply to benefit design and provider networks;  Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and   Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.accessbettercoverage.org/states/new-mexico

VIDEO: PhRMA CEO joins CNBC’s Squawk on the Street to discuss industry campaign #GOBOLDLY

PhRMA  |  Blog Post

    Visit GoBoldly.com and Innovation.org to learn more about #GOBOLDLY.
http://catalyst.phrma.org/video-phrma-ceo-joins-cnbcs-squawk-on-the-street-to-discuss-new-industry-campaign-go-boldly

New Mexico's 2016 Exchange Plans

PhRMA  |  Fact Sheet

States can continue to protect patients in their state through the following actions: Enforcing non-discrimination requirements, which apply to benefit design and provider networks; Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.phrma.org/fact-sheet/new-mexico-s-2016-exchange-plans

Biogen CEO George A. Scangos Becomes PhRMA Board Chairman

PhRMA  |  Press Release

Jimenez has been CEO of Novartis since 2010.
http://www.phrma.org/press-release/biogen-ceo-george-a-scangos-becomes-phrma-board-chairman

PhRMA Statement on Prescription Drug User Fee Act Reauthorization

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/phrma-statement-on-prescription-drug-user-fee-act-reauthorization

Prescription Drug User Fee Act

From Hope To Cures  |  From Our Network

...
http://www.fromhopetocures.org/glossary

National Drug Take Back Day

PhRMA  |  Blog Post

In addition to DEA’s National Take Back Day, local communities will often organize a local medication take back event during various times of the year.
http://catalyst.phrma.org/national-drug-take-back-day

PhRMA & BIO release joint principles on communications with health care professionals and payers

PhRMA  |  Blog Post

Learn more about communications with health care professionals and payers here.
http://catalyst.phrma.org/phrma-bio-release-joint-principles-on-communications-with-health-care-professionals-and-payers

Because One Day Isn't Enough

PhRMA  |  Blog Post

So, I imagine my $400 or so (I no longer remember the exact amount) probably didn't get too far.
http://catalyst.phrma.org/because-one-day-isnt-enough

You have reviewed the first 50 results out of 1971. Each page contains 25 results. You're on page 2.

prev 1 2 3 4 5 6 next